Aurora Cannabis Inc. ACB
At closeNov 5, 2026, 8:28 AM EST
Pre-market · Nov 5, 8:28 AM ET
- YTD
- +24.17%
- 1 year
- +17.49%
- Market cap
- 331.74M
- Revenue (ttm)
- 296.99M
- Profit margin
- -14.71%
- EPS (ttm)
- -0.61
- Shares out
- 54.88M
- Forward P/E
- -38.82
- YTD return
- +24.17%
- 1-year return
- +17.49%
- Volume
- 3.13M
- Avg volume
- 1.41M
- Open
- 5.16
- Previous close
- 5.16
- Day's range
- 5.10 – 5.26
- 52-week range
- 2.56 – 6.36
- Beta
- 2.70
- Analysts
- Buy
- Earnings date
- Feb 13, 2025
5D +1.18 (+29.06%)
Key statistics
- Enterprise value
- 233.55B
- PEG ratio
- 0.00
- Price / sales
- 0.79
- Price / book
- 427.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 28.50%
- Free cash flow
- -84.08M
- Total cash
- 84.92M
- Total debt
- 100.97M
- Return on equity
- -5.79%
- Short % of float
- 0.00%
- 50-day average
- 4.88
- 200-day average
- 5.62
Analyst view
Consensus: buy
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 13, 2025
Expected Feb 13, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.04 | — | — | — |
| Nov 6, 2024 | Sep 1, 2024 | -0.22 | 0.04 | +0.26 | +118.18% |
| Aug 7, 2024 | Jun 1, 2024 | -0.35 | -0.11 | +0.24 | +68.57% |
| Aug 7, 2024 | Jun 1, 2024 | -0.35 | — | — | — |
| Jun 20, 2024 | Mar 1, 2024 | -0.18 | 0.11 | +0.29 | +161.11% |
| Jun 20, 2024 | Mar 1, 2024 | -0.18 | — | — | — |
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- auroramj.com
News
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results 
Aurora Cannabis Stock: What Organigram's Buyout Means for Investors 
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis 
Aurora Cannabis Stock Surges on Organigram Deal 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
Organigram to Acquire Aurora and Establish a Global Cannabis Leader 
Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share 
Organigram to Acquire Aurora and Establish a Global Cannabis Leader 
Sigma Lithium upsizes convertible bond offering to $125 million 
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
Your note
Sign in to keep a note on ACB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Beauchamp (Norma) | Director of Issuer | Acquisition or disposition in the public market | Nov 14, 2022 | 2,595 |
| Clark (Nathalie) | Senior Officer of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 2,700 |
| Funk, Ronald | Director of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 56,752 |
| Ibbott William Glen | Senior Officer of Issuer | Acquisition or disposition in the public market | Jun 6, 2022 | 43,048 |
| Jerome (Andre) | Senior Officer of Issuer | Exercise of rights | Nov 22, 2022 | 35,052 |
| Kohli (Chitwant S) | Director of Issuer | Acquisition or disposition in the public market | May 30, 2022 | 60,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Tidal Investments, LLC | 2.45% | 1,344,321 | 5.74M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.20% | 658,255 | 2.81M | Sep 29, 2024 |
| Goldman Sachs Group Inc | 0.73% | 402,814 | 1.72M | Sep 29, 2024 |
| Morgan Stanley | 0.36% | 194,820 | 831.88K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.29% | 159,051 | 679.15K | Sep 29, 2024 |
| Jane Street Group, LLC | 0.24% | 129,343 | 552.29K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify ETF Tr-Amplify Alternative Harvest ETF | 2.45% | 1,341,643 | 5.73M | Sep 29, 2024 |
| DFA Investment Dimensions-Canadian Small Company Series | 0.11% | 61,293 | 261.72K | Jul 30, 2024 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.08% | 45,349 | 193.64K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 32,486 | 138.72K | Oct 30, 2024 |
| DFA International Core Equity Portfolio | 0.03% | 14,401 | 61.49K | Jul 30, 2024 |
| SPDR Portfolio Developed World ex-US ETF | 0.01% | 7,232 | 30.88K | Sep 29, 2024 |